Attention-Deficit/Hyperactivity Disorder Archives - Psychiatry Advisor

Attention-Deficit/Hyperactivity Disorder

Adhansia XR Soon to Be Available for ADHD

Adhansia XR (methylphenidate HCl extended-release capsules) is expected to be available as of July 15, 2019 for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older, according to Adlon Therapeutics.

Can Maternal Diet Affect the Risk of ADHD Development in Offspring?

A higher omega-6 to omega-3 ratio in the mother’s diet may increase the risk of attention deficit hyperactivity disorder (ADHD) symptoms in offspring, according to findings from a study published in the Journal of Pediatrics. Researchers quantified the levels of omega-6 and -3 that reached the fetus by sampling umbilical cord plasma. Omega-3 and omega-6…

Next post in ADHD